Case selection for statins was similar in two Canadian provinces: BC and Ontario
JM Paterson, G Carney, GM Anderson, K Bassett… - Journal of clinical …, 2007 - Elsevier
OBJECTIVES: Though statins are fully reimbursed by the public drug programs for seniors in
British Columbia (BC) and Ontario, Canada, population-based rates of statin prescription are …
British Columbia (BC) and Ontario, Canada, population-based rates of statin prescription are …
[HTML][HTML] Medication Reimbursement Model and Cost Savings in a Canadian Ambulatory Hemodialysis Program
JAS Wilson, J Tran, A Veith, D Landry… - … Canadian Journal of …, 2019 - ncbi.nlm.nih.gov
Hemodialysis (HD) units in Canada provide dialysis treatment and medication therapy to
patients with advanced chronic kidney disease. IV iron is commonly indicated for iron …
patients with advanced chronic kidney disease. IV iron is commonly indicated for iron …
[PDF][PDF] Prescription drugs are not covered: Examining the impact of Canada's lack of a Pharmacare program
MH Abramovitch - 2017 - ruor.uottawa.ca
The cost of an appointment for receiving medical care from a doctor is, with a few
exceptions, covered through provincial health care plans. Frequently the result of visiting a …
exceptions, covered through provincial health care plans. Frequently the result of visiting a …
The Liberal Party of Canada's Proposal for Nationwide Universal Pharmacare: Informing the Path Forward Via International Comparison
S Wadhawa - 2021 - yorkspace.library.yorku.ca
Abstract In 2019, the Liberal Party of Canada (LPC) tabled the most recent proposal
(Hoskins Report) for nationwide Pharmacare. It made sixty recommendations on how to …
(Hoskins Report) for nationwide Pharmacare. It made sixty recommendations on how to …
[PDF][PDF] Essays on Pharmaceutical Economics
A Shajarizadeh - 2016 - prism.ucalgary.ca
Essays on Pharmaceutical Economics Page 1 University of Calgary PRISM Repository https://prism.ucalgary.ca
The Vault Open Theses and Dissertations 2016 Essays on Pharmaceutical Economics …
The Vault Open Theses and Dissertations 2016 Essays on Pharmaceutical Economics …
Assurance-médicaments nationale: Le moment d'aller de l'avant
L Salehi - Canadian Family Physician, 2016 - cfp.ca
Le Canada fait figure d'exception parmi les pays très développés en raison de sa curieuse
façon d'exclure la couverture des médicaments d'ordonnance dans son programme …
façon d'exclure la couverture des médicaments d'ordonnance dans son programme …
National pharmacare: Time to move forward
L Salehi - Canadian Family Physician, 2016 - cfp.ca
Canada is unique among highly developed countries in its curious exclusion of prescription
drug coverage from its universal health insurance program, as well as its comparatively high …
drug coverage from its universal health insurance program, as well as its comparatively high …
[PDF][PDF] How the pace of change affects the scope of reform: Pharmaceutical insurance in Canada, Australia and the UK
K Boothe - academia.edu
Abstract∗ When policy change is considered, what determines its success or failure? Why
do plans for broad reforms often fall short, and why do certain types of change become more …
do plans for broad reforms often fall short, and why do certain types of change become more …
Insurance Risks as Fictitious Commodities: The Institutional Constitution of Insurance Markets
M Charbonneau - 2017 - repository.library.carleton.ca
This dissertation aims at shifting the focus in the emerging sociology of insurance literature
from the epistemic and cultural construction of private insurability towards the political-legal …
from the epistemic and cultural construction of private insurability towards the political-legal …